Improving Osteoporosis Care in a Home Health Setting
NCT01109472 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1009
Last updated 2013-12-23
Summary
Study aims to improve osteoporosis care through patient tailored education materials in a group-randomized trial of patients referred to home health care with a history of fracture and/or an osteoporosis diagnosis. Project investigators will conduct telephone surveys and examine electronic medical record data to assess fracture related morbidity and mortality, osteoporosis treatment and adherence, and use of calcium and vitamin D supplements.
We hypothesize that patients that receive the intervention materials will be more likely to initiate or maintain osteoporosis treatment.
Conditions
Interventions
- OTHER
-
patient magazine
patient magazine individually tailored to patient's prior feedback
Sponsors & Collaborators
- collaborator INDUSTRY
-
Alacare Home Health and Hospice
collaborator OTHER -
University of Alabama at Birmingham
lead OTHER
Principal Investigators
-
Jeffrey R Curtis, MD, MPH · University of Alabama at Birmingham
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-04-30
- Primary Completion
- 2012-08-31
- Completion
- 2012-11-30
More Related Trials
-
The Study of the Early Administration of Alendronate on Prevention of Bone Loss After Hip Fracture.
NCT00346190 ·Status: UNKNOWN ·Phase: PHASE3
-
Low-Dose Hormone Replacement Therapy and Alendronate for Osteoporosis
NCT00000430 ·Status: TERMINATED ·Phase: PHASE3
-
Alendronate Prevents Microarchitectural Deterioration of Trabecular Bone in Early Postmenopausal Women
NCT00504166 ·Status: COMPLETED ·Phase: PHASE4
-
Osteoporosis Prevention With Low Dose Alendronate
NCT00463268 ·Status: COMPLETED ·Phase: PHASE3
-
Alendronate and/or Parathyroid Hormone for Osteoporosis
NCT00000400 ·Status: COMPLETED ·Phase: PHASE2
-
Adherence to Osteoporosis Treatment and Physicians' Perception Regarding Osteoporosis Medication
NCT02472782 ·Status: COMPLETED
-
Clinical Study Evaluating Beta Blockers Use and Fracture Risk in Patients With Primary Osteoporosis
NCT04704947 ·Status: RECRUITING ·Phase: PHASE3
-
Twenty-Four Month Extension Study of BA058-05-003 (Abaloparatide) in Participants With Osteoporosis
NCT01657162 ·Status: COMPLETED ·Phase: PHASE3
-
MK-5442 in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With an Oral Bisphosphonate (MK-5442-012)
NCT00996801 ·Status: COMPLETED ·Phase: PHASE2
-
µMRI of Therapeutic Intervention in Postmenopausal Osteoporosis
NCT01153425 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Alendronate to Prevent and Treat Osteoporosis in Cystic Fibrosis Patients
NCT00157690 ·Status: COMPLETED ·Phase: PHASE4
-
Prevention of Osteoporosis in Men With Prostate Cancer
NCT00048841 ·Status: COMPLETED ·Phase: PHASE3
-
The Change of Bone Markers After Low Dose Alendronate in Postmenopausal Women With Bone Loss
NCT00460057 ·Status: COMPLETED ·Phase: PHASE4
-
Teriparatide Treatment in Patients With Inherited Osteoporosis
NCT01360424 ·Status: COMPLETED ·Phase: PHASE4
-
Precision Medicine Approach for Osteoporosis - Follow Up Study
NCT06264609 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Evaluation of Osteo-Buddy in Improving Osteoporosis Knowledge
NCT07034131 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effects of Parathyroid Hormone in Men With Osteoporosis
NCT00000427 ·Status: COMPLETED ·Phase: PHASE3
-
Anabolic Therapy in Postmenopausal Osteoporosis
NCT05010590 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Randomized Study of Alendronate in Adult Patients With Cystic Fibrosis Related Osteoporosis
NCT00004489 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Zoledronic Acid in the Prevention and Treatment of Corticosteroid Induced Osteoporosis
NCT00100620 ·Status: COMPLETED ·Phase: PHASE3
-
Exploring Efficacy, Cost Effectiveness and Experiences Related to Adherence of Different Bisphosphonate Regimens for the Prevention of Osteoporotic Fragility Fractures.
NCT04283786 ·Status: COMPLETED
-
Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy
NCT00329797 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal Women
NCT01343004 ·Status: COMPLETED ·Phase: PHASE3
-
Characteristics and Management of Postmenopausal Women With Osteoporosis Treated With Prolia® in France
NCT02347865 ·Status: COMPLETED
-
TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis
NCT00172081 ·Status: COMPLETED ·Phase: PHASE3